A latest market study report has come on Peptides therapeutics. Future Market Insights has published the report on peptides therapeutics global market insight. According to the report, peptides are potentially being developed as a large market and will expand with CAGR of 10.3% during the time frame of 2015-2025. Peptides are being used as therapeutic agents from 1950s and they were closely related to the hormones. But the new indications of peptides are approved as therapeutics to treat many problems like inflammation, CNS disorders, hematology, urology, cardiovascular disorders, and metabolic disorders. By seeing the present demand of peptides, the report has projected the market growth to exceed $46 billion by 2025. You can read the full report here.

Among all the applications of peptide therapeutics, cancer application had dominated the market in 2015 and it is continuously running on the same path to dominate the global peptide therapeutics market during the forecast period. Metabolic disorders are the second reason for the use of USA peptides. But the market of endocrinology application is declining. It is also expected to expand at the highest CAGR over 2015-2025 due to its approval in other locations.

There is a growth seen in new approvals for peptides in several locations across the world and it will help to increase the growth in global peptide therapeutics market value. There is also a growth in the number of commercially approved peptide therapeutics. Till 2000, there were only 43 approved peptide therapeutics in the US, Europe, and Japan. Within two decades, now in 2019, there are more than 100 approved peptide therapeutics evaluated in pre-clinical stage. For region-wise, North America is seen to dominate the global market for peptide therapeutics.